Ghent University Academic Bibliography

Advanced

New options for molecular therapy of neuroblastoma: from p53 to gene therapy

Tom Van Maerken UGent (2011)
Please use this url to cite or link to this publication:
author
promoter
UGent and UGent
organization
year
type
dissertation (monograph)
subject
keyword
gene therapy, MDM2, molecular therapy, hPNPase, nutlin-3, Neuroblastoma, p53
pages
188 pages
publisher
Ghent University. Faculty of Medicine and Health Sciences
place of publication
Ghent, Belgium
defense location
Gent : UZ (auditorium C)
defense date
2011-01-11 17:00
ISBN
9789490695484
language
English
UGent publication?
yes
classification
D1
additional info
dissertation consists of copyrighted material
copyright statement
I have transferred the copyright for this publication to the publisher
id
1150297
handle
http://hdl.handle.net/1854/LU-1150297
date created
2011-02-14 23:42:24
date last changed
2012-02-03 08:44:00
@phdthesis{1150297,
  author       = {Van Maerken, Tom},
  isbn         = {9789490695484},
  keyword      = {gene therapy,MDM2,molecular therapy,hPNPase,nutlin-3,Neuroblastoma,p53},
  language     = {eng},
  pages        = {188},
  publisher    = {Ghent University. Faculty of Medicine and Health Sciences},
  school       = {Ghent University},
  title        = {New options for molecular therapy of neuroblastoma: from p53 to gene therapy},
  year         = {2011},
}

Chicago
Van Maerken, Tom. 2011. “New Options for Molecular Therapy of Neuroblastoma: From P53 to Gene Therapy”. Ghent, Belgium: Ghent University. Faculty of Medicine and Health Sciences.
APA
Van Maerken, T. (2011). New options for molecular therapy of neuroblastoma: from p53 to gene therapy. Ghent University. Faculty of Medicine and Health Sciences, Ghent, Belgium.
Vancouver
1.
Van Maerken T. New options for molecular therapy of neuroblastoma: from p53 to gene therapy. [Ghent, Belgium]: Ghent University. Faculty of Medicine and Health Sciences; 2011.
MLA
Van Maerken, Tom. “New Options for Molecular Therapy of Neuroblastoma: From P53 to Gene Therapy.” 2011 : n. pag. Print.